We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

46 hedge funds and large institutions have $29.8M invested in Vaxart in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $29.5M → $29.8M (+$252K)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

6% less funds holding

Funds holding: 4946 (-3)

22% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 9

Holders
46
Holders Change
-3
Holders Change %
-6.12%
% of All Funds
1.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
11
Reduced
12
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Envestnet Asset Management
51
Envestnet Asset Management
Illinois
-$1K -38 Closed
HF
52
Hoxton Financial
West Virginia
+$128 +5 New

VXRT Hedge Fund Activity: Q4 2014 in Review

46 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2014, worth a combined $29.8M — up 0.85% from $29.5M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of VXRT and 7 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 11 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $3.21M. The largest seller was JP Morgan Chase, cutting an estimated $2.78M.

  • 46 institutional investors held Vaxart (VXRT) as of Q4 2014, down from 49 in Q3 2014.
  • Funds reported $29.8M of Vaxart stock for Q4 2014, up 0.85% quarter-over-quarter.
  • 7 funds opened new Vaxart positions in Q4 2014 and 9 closed out, a net change of -2 holders.
  • The largest Vaxart buyer in Q4 2014 was RA Capital Management, an estimated $3.21M added.
  • The largest Vaxart seller in Q4 2014 was JP Morgan Chase, an estimated $2.78M sold.

Based on aggregated 13F filings for Q4 2014.